| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |